These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2356204)

  • 1. Behavioral and biochemical correlates of chronic administration of quipazine.
    Valencia-Flores M; Campos-Sepulveda E; Galindo-Morales JA; Lujan M; Colotla VA
    Pharmacol Biochem Behav; 1990 Jun; 36(2):299-304. PubMed ID: 2356204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic administration of fenfluramine and quipazine on body weight gain after ovariectomy and on brain serotonin receptor binding.
    Rowland N; Carlton J; Bartness T; Smith G
    Behav Neurosci; 1983 Jun; 97(3):502-5. PubMed ID: 6683563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of quipazine, a selective 5-HT3 agonist, on dietary self-selection of different macronutrient diets in male and female rats.
    Mok E; Paquette M; Thibault L
    Appetite; 2000 Jun; 34(3):313-25. PubMed ID: 10888295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
    Hewson G; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quipazine-induced behavior in neonatal rat pups.
    Spear LP; Ristine LA
    Pharmacol Biochem Behav; 1981 Jun; 14(6):831-4. PubMed ID: 7255519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quipazine antagonizing baclofen activity. Influence of baclofen and gamma-hydroxybutyric acid on serotonin metabolism in rat brain (author's transl)].
    Waldmeier PC; Maître L
    Arzneimittelforschung; 1978; 28(9):1507-8. PubMed ID: 582544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preweaning cocaine administration alters the adult response to quipazine: comparison with fluoxetine.
    Dow-Edwards DL
    Neurotoxicol Teratol; 1998; 20(2):133-42. PubMed ID: 9536459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.
    Smith RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1990 Aug; 254(2):484-8. PubMed ID: 2166792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of anorexia and motor disruption by cyclazocine and quipazine.
    Henck JW; Rezabek DH; Rech RH
    Pharmacol Biochem Behav; 1985 May; 22(5):671-6. PubMed ID: 4011631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metergoline and quipazine on locomotor activity of rats in novel and familiar environments.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 May; 20(5):701-5. PubMed ID: 6739514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of quipazine and fluoxetine on extinction of a previously-reinforced operant response in rats.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 Oct; 21(4):533-7. PubMed ID: 6334317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
    Friedman RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.
    Feigenbaum JJ; Yanai J; Klawans HL
    J Neural Transm; 1983; 57(1-2):27-37. PubMed ID: 6619829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different behavioral mechanisms underlie tolerance to the anorectic effects of fenfluramine and quipazine.
    Rowland N; Carlton J
    Psychopharmacology (Berl); 1983; 81(2):155-7. PubMed ID: 6415747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
    Vickers SP; Benwell KR; Porter RH; Bickerdike MJ; Kennett GA; Dourish CT
    Br J Pharmacol; 2000 Jul; 130(6):1305-14. PubMed ID: 10903970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and the mammalian circadian system: II. Phase-shifting rat behavioral rhythms with serotonergic agonists.
    Edgar DM; Miller JD; Prosser RA; Dean RR; Dement WC
    J Biol Rhythms; 1993; 8(1):17-31. PubMed ID: 8490208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quipazine induced wet dog shake behaviour in rats: mechanism of action.
    Hiremagalur ; Keshavan JH; Dandiya PC; Gurbani NK
    Pharmacol Res Commun; 1980 Sep; 12(8):757-68. PubMed ID: 6160597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.